Picture of Nephros logo

NEPH — Nephros News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousMicro CapNeutral

Nephros Inc expected to post a loss of 11 cents a share - Earnings Preview

* Nephros Inc  NEPH.OQ   NEPH.O  is expected to show a fall
in
quarterly revenue when it reports  results on November 2. 
    * The South Orange New Jersey-based  company is expected to
report
 a 0.8% decrease in revenue to $2.616 million from $2.64 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. The company's guidance on October 11
2022, for the period ended September 30, was for revenue of
$2.500 million.
    * ​Refinitiv's mean analyst estimate for Nephros Inc is for
a loss
of 11 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Nephros Inc
is
$3.63​, above​ its last closing price of $1.05. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.15       -0.15      -0.12     Beat    18.9
 Mar. 31 2022  -0.10       -0.11      -0.20     Missed  -87.5
 Dec. 31 2021  -0.11       -0.11      -0.11     Met     2.9​
 Sep. 30 2021  -0.10       -0.10      -0.12     Missed  -14.3
 ​​Jun.        -0.11       -0.11      -0.12     Missed  -5.9
 30 2021                                                
 Mar. 31 2021  -0.12       -0.12      -0.11     Beat    7.6​
 Dec. 31 2020  -0.12       -0.11      -0.08     Beat    27.3
 Sep. 30 2020  -0.14       -0.14      -0.12     Beat    12.2
 This summary was machine generated November 1 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Nephros

See all news